Vascular News – CX Special Edition 2019

474

In this issue:

  • CX 2019 highlights
  • A year in profiles
  • US FDA continues to investigate paclitaxel devices in the leg
  • European vascular community continues to dispute draft NICE AAA guidelines amidst publication delays

 


LEAVE A REPLY

Please enter your comment!
Please enter your name here